Rong Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rong Peng has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Lijun Yang
Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China
3 shared publications- Can Cui
Tsinghua University
1 shared publication Chao Huang
Department of Critical Medicine Affiliated Hospital of Chengdu University Chengdu Sichuan China
1 shared publication- Chengfu Wang
School of Electrical Engineering, Shandong University, Jinan 250061, China
1 shared publication Fei Yuan
Taian Power Supply Company, State Grid Shandong Electric Power Company,Taian,China
1 shared publicationFeng Chen
School of Basic Medicine and Nursing, Chengdu University, Chengdu, Sichuan, China
1 shared publication
Latest Publications
- Open Access
- 10 November 2023
- Published by Elsevier in Preventive Medicine Reports
- Vol. 36, 102511
Global burden and inequality of autism spectrum disorders: Based on data from the 2019 Global Burden of Disease study
- 10 November 2023
- Published by Elsevier in Preventive Medicine Reports
- Vol. 36, 102511
Open AccessGlobal burden and inequality of autism spectrum disorders: Based on data from the 2019 Global Burden of Disease study
- Open Access
- 29 September 2023
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 117 (1) , 24-37
Global burden and inequality of maternal and neonatal disorders: based on data from the 2019 Global Burden of Disease study
Summary: Background: Maternal and neonatal disorders account for substantial health loss across the lifespan from early childhood. These problems may be related to health inequality. Aim: To provide evidence for improvement in health policies regarding maternal and neonatal disorder inequity. Design: This was a population-based cross-sectional study based on 2019 Global Burden of Disease data. Methods: Annual cases and age-standardized rates (ASRs) of incidence, prevalence, death, and disability-adjusted life-years (DALYs) in maternal and neonatal disorders between 1990 and 2019 were collected from the 2019 Global Burden of Disease study. Concentration curves and concentration indices were used to summarize the degree of socioeconomic-related inequality. Results: For maternal disorders, the global ASRs of incidence, prevalence, death and DALYs were 2889.4 (95% uncertainty interval (UI), 2562.9–3251.9), 502.9 (95% UI 418.7–598.0), 5.0 (95% UI 4.4–5.8) and 324.9 (95% UI 284.0–369.1) per 100 000 women in 2019, respectively. The ASRs of maternal disorders were all obviously reduced and remained pro-poor from 1990 to 2019. In neonatal disorders, the global ASRs of incidence, prevalence, death and DALYs were 363.3 (95% UI 334.6–396.8), 1239.8 (95% UI 1142.1–1356.7), 29.1 (95% UI 24.8–34.5) and 2828.3 (95% UI 2441.6–3329.6) per 100 000 people in 2019, respectively. The global ASRs of incidence, death and DALYs in neonatal disorders have remained pro-poor. However, the socioeconomic-related fairness in the ASR of neonatal disorder prevalence is being levelled. Conclusions: The global burden of maternal and neonatal disorders has remained high, and socioeconomic-related inequality (pro-poor) tended not to change between 1990 and 2019.
- 29 September 2023
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 117 (1) , 24-37
Open AccessGlobal burden and inequality of maternal and neonatal disorders: based on data from the 2019 Global Burden of Disease study
Summary: Background: Maternal and neonatal disorders account for substantial health loss across the lifespan from early childhood. These problems may be related to health inequality. Aim: To provide evidence for improvement in health policies regarding maternal and neonatal disorder inequity. Design: This was a population-based cross-sectional study based on 2019 Global Burden of Disease data. Methods: Annual cases and age-standardized rates (ASRs) of incidence, prevalence, death, and disability-adjusted life-years (DALYs) in maternal and neonatal disorders between 1990 and 2019 were collected from the 2019 Global Burden of Disease study. Concentration curves and concentration indices were used to summarize the degree of socioeconomic-related inequality. Results: For maternal disorders, the global ASRs of incidence, prevalence, death and DALYs were 2889.4 (95% uncertainty interval (UI), 2562.9–3251.9), 502.9 (95% UI 418.7–598.0), 5.0 (95% UI 4.4–5.8) and 324.9 (95% UI 284.0–369.1) per 100 000 women in 2019, respectively. The ASRs of maternal disorders were all obviously reduced and remained pro-poor from 1990 to 2019. In neonatal disorders, the global ASRs of incidence, prevalence, death and DALYs were 363.3 (95% UI 334.6–396.8), 1239.8 (95% UI 1142.1–1356.7), 29.1 (95% UI 24.8–34.5) and 2828.3 (95% UI 2441.6–3329.6) per 100 000 people in 2019, respectively. The global ASRs of incidence, death and DALYs in neonatal disorders have remained pro-poor. However, the socioeconomic-related fairness in the ASR of neonatal disorder prevalence is being levelled. Conclusions: The global burden of maternal and neonatal disorders has remained high, and socioeconomic-related inequality (pro-poor) tended not to change between 1990 and 2019.
- 7 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1685-1692
Wind-storage Control Strategy Considering the Electro-Thermal Coupling Characteristics of Overhead Lines
When large-scale wind power is connected to the grid through overhead transmission lines (OTLs), it will cause the problem of power fluctuation and line transmission capacity exceeding the limit, which seriously endangers the stable operation of power system. In this paper, reasonable wind abandonment is carried out to meet the transmission capacity constraint based on electro-thermal coupling theory. Meanwhile, the output power after wind abandonment is stabilized by hybrid energy storage to further meet the requirements of wind power grid-connected volatility. First, the wind-storage integration model is established. Then, based on the electro-thermal coupling theory, a wind abandonment strategy is established to meet the transmission capacity constraints of the OTLs, which uses real-time meteorological parameters to calculate the standard of wind abandonment. Then, taking the output power after wind abandonment as input, a wind-storage control strategy based on hybrid energy storage is established, which can adjust wind power output to meet the constraints of wind power grid-connected volatility. Finally, case analysis shows that the proposed strategy can not only realize the safe grid-connection of wind power, but also reasonably distribute the hybrid energy storage power instructions.
- 7 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1685-1692
Wind-storage Control Strategy Considering the Electro-Thermal Coupling Characteristics of Overhead Lines
When large-scale wind power is connected to the grid through overhead transmission lines (OTLs), it will cause the problem of power fluctuation and line transmission capacity exceeding the limit, which seriously endangers the stable operation of power system. In this paper, reasonable wind abandonment is carried out to meet the transmission capacity constraint based on electro-thermal coupling theory. Meanwhile, the output power after wind abandonment is stabilized by hybrid energy storage to further meet the requirements of wind power grid-connected volatility. First, the wind-storage integration model is established. Then, based on the electro-thermal coupling theory, a wind abandonment strategy is established to meet the transmission capacity constraints of the OTLs, which uses real-time meteorological parameters to calculate the standard of wind abandonment. Then, taking the output power after wind abandonment as input, a wind-storage control strategy based on hybrid energy storage is established, which can adjust wind power output to meet the constraints of wind power grid-connected volatility. Finally, case analysis shows that the proposed strategy can not only realize the safe grid-connection of wind power, but also reasonably distribute the hybrid energy storage power instructions.
- Open Access
- 4 February 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (5) , 2181-2187
Correlation between vaccine coverage and the COVID‐19 pandemic throughout the world: Based on real‐world data
The aim of the study was to examine the correlation between COVID‐19 vaccine coverage rates and outcomes of the COVID‐19 epidemic in the case of COVID‐19 variants based on real‐world data. The data came from Our World in Data, which is building the international COVID‐19 vaccination data set and is an open‐source data set for everyone to use. The vaccination data set uses the most recent official numbers from governments and health ministries worldwide. We assessed the correlation between COVID‐19 vaccine coverage rates and outcomes of the COVID‐19 epidemic with existing variants by performing temporal analysis and spatial analysis. Overall, new cases per million population, the reproduction rate of COVID‐19, new deaths from all causes per million population, excess mortality attributed to COVID‐19 pandemic, and hospital patients or intensive care unit (ICU) patients per million population were not decreased with the time course. However, at the same time point, new cases per million population, the reproduction rate of COVID‐19, new deaths per million population, and hospital patients or ICU patients per million population gradually decreased as the rate of vaccination coverage increased. High coverage percentages of COVID‐19 vaccination were negatively correlated with the reproduction rate of COVID‐19 (correlation coefficient −0.116) and ICU patients per million of the local population (correlation coefficient −0.055). Currently, there is no effective treatment for the COVID‐19 pandemic, and prevention of the COVID‐19 pandemic mainly depends on vaccines, especially when the rate of COVID‐19 vaccine coverage is over 60%. The benefits of preventing severe disease and preventing transmission of infection are likely to be obvious.
- 4 February 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (5) , 2181-2187
Open AccessCorrelation between vaccine coverage and the COVID‐19 pandemic throughout the world: Based on real‐world data
The aim of the study was to examine the correlation between COVID‐19 vaccine coverage rates and outcomes of the COVID‐19 epidemic in the case of COVID‐19 variants based on real‐world data. The data came from Our World in Data, which is building the international COVID‐19 vaccination data set and is an open‐source data set for everyone to use. The vaccination data set uses the most recent official numbers from governments and health ministries worldwide. We assessed the correlation between COVID‐19 vaccine coverage rates and outcomes of the COVID‐19 epidemic with existing variants by performing temporal analysis and spatial analysis. Overall, new cases per million population, the reproduction rate of COVID‐19, new deaths from all causes per million population, excess mortality attributed to COVID‐19 pandemic, and hospital patients or intensive care unit (ICU) patients per million population were not decreased with the time course. However, at the same time point, new cases per million population, the reproduction rate of COVID‐19, new deaths per million population, and hospital patients or ICU patients per million population gradually decreased as the rate of vaccination coverage increased. High coverage percentages of COVID‐19 vaccination were negatively correlated with the reproduction rate of COVID‐19 (correlation coefficient −0.116) and ICU patients per million of the local population (correlation coefficient −0.055). Currently, there is no effective treatment for the COVID‐19 pandemic, and prevention of the COVID‐19 pandemic mainly depends on vaccines, especially when the rate of COVID‐19 vaccine coverage is over 60%. The benefits of preventing severe disease and preventing transmission of infection are likely to be obvious.
- Open Access
Immunonutrition for traumatic brain injury in children and adolescents: protocol for a systematic review and meta-analysis
Introduction Traumatic brain injury (TBI) is the leading cause of paediatric trauma death and disability worldwide. The ‘Guidelines for the Management of Severe Traumatic Brain Injury (Fourth Edition)’ recommend that nutritional goals should be achieved within 5–7 days of injury. Immune-enhancing nutrition or immunonutrition, referring to the addition of specialised nutrients, including glutamine, alanine, omega-3 fatty acids and nucleotides, to standard nutrition formulas, may improve surgical outcomes in the perioperative period. However, the role of immune-enhancing nutritional supplements for patients with paediatric TBI remains unclear. We will conduct a systematic review to determine the efficacy and safety of immunonutrition for patients with paediatric TBI and provide evidence for clinical decision-making. Methods and analysis Studies reporting immune-enhancing nutrition treatments for patients with paediatric TBI will be included. Outcomes of interest include the length of hospital stay, wound infections, all-cause mortality, non-wound infection, including pneumonia, urinary tract infection and bacteraemia, and the reports adverse events. Duration of follow-up has no restriction. Primary studies consisting of randomised controlled trials (RCTs) and non-RCTs will be eligible for this review, and only studies published in English will be included. We will search the Medline, Embase and Cochrane Library databases from their inception dates to January 2020. We will also search clinicaltrials.gov and the WHO International Clinical Trials Registry Platform for additional information. Two reviewers will independently select studies and extract data. Risk-of-bias will be assessed with tools based on the Cochrane risk-of-bias criteria and Newcastle-Ottawa Quality Assessment Scale. A meta-analysis will be used to pool data when there are sufficient studies with homogeneity. Heterogeneity of the estimates across studies will be assessed; if necessary, a subgroup analysis will be performed to explore the source of heterogeneity. The Grades of Recommendation, Assessment, Development and Evaluation method will be applied to assess the level of evidence obtained from this systematic review. Ethics and dissemination The proposed systematic review and meta-analysis will be based on published data, and thus ethical approval is not required. The results of this review will be published. PROSPERO registration number CRD42020154814.
Open AccessImmunonutrition for traumatic brain injury in children and adolescents: protocol for a systematic review and meta-analysis
Introduction Traumatic brain injury (TBI) is the leading cause of paediatric trauma death and disability worldwide. The ‘Guidelines for the Management of Severe Traumatic Brain Injury (Fourth Edition)’ recommend that nutritional goals should be achieved within 5–7 days of injury. Immune-enhancing nutrition or immunonutrition, referring to the addition of specialised nutrients, including glutamine, alanine, omega-3 fatty acids and nucleotides, to standard nutrition formulas, may improve surgical outcomes in the perioperative period. However, the role of immune-enhancing nutritional supplements for patients with paediatric TBI remains unclear. We will conduct a systematic review to determine the efficacy and safety of immunonutrition for patients with paediatric TBI and provide evidence for clinical decision-making. Methods and analysis Studies reporting immune-enhancing nutrition treatments for patients with paediatric TBI will be included. Outcomes of interest include the length of hospital stay, wound infections, all-cause mortality, non-wound infection, including pneumonia, urinary tract infection and bacteraemia, and the reports adverse events. Duration of follow-up has no restriction. Primary studies consisting of randomised controlled trials (RCTs) and non-RCTs will be eligible for this review, and only studies published in English will be included. We will search the Medline, Embase and Cochrane Library databases from their inception dates to January 2020. We will also search clinicaltrials.gov and the WHO International Clinical Trials Registry Platform for additional information. Two reviewers will independently select studies and extract data. Risk-of-bias will be assessed with tools based on the Cochrane risk-of-bias criteria and Newcastle-Ottawa Quality Assessment Scale. A meta-analysis will be used to pool data when there are sufficient studies with homogeneity. Heterogeneity of the estimates across studies will be assessed; if necessary, a subgroup analysis will be performed to explore the source of heterogeneity. The Grades of Recommendation, Assessment, Development and Evaluation method will be applied to assess the level of evidence obtained from this systematic review. Ethics and dissemination The proposed systematic review and meta-analysis will be based on published data, and thus ethical approval is not required. The results of this review will be published. PROSPERO registration number CRD42020154814.
- 1 January 2020
- Published by Elsevier in Clinical Nutrition
- Vol. 39 (1) , 307-309
The efficacy and safety of administration of prokinetics improve clinical outcomes in critically ill patients is still quite unclear
- 1 January 2020
- Published by Elsevier in Clinical Nutrition
- Vol. 39 (1) , 307-309
The efficacy and safety of administration of prokinetics improve clinical outcomes in critically ill patients is still quite unclear